Page 132 - 76_01

RAMÓN GARCÍA-DOMÉNECH Y COLS. AN. R. ACAD. NAC. FARM.

6. BIBLIOGRAFÍA

1. http://www.who.int/mediacentre/news/releases/2007/pr61/es/index.html.
2. Llibre, J. M.; Falco, V.; Tural, C.; Negredo, E.; Pineda, J. A.; Muñoz, J.; Ortega,

E.; Videla, S.; Sirera, G.; Martínez, E.; Miralles, C.; Iribarren, J.; Galindo, M.
J.; Domingo, P.; D’Arminio-Monforte, A.; Miró, J. M. & Clotet, B. (2009) The
changing face of HIV/AIDS in treated patients. Current HIV Research. 7(4):
365-77.
3. Almerico, A. M.; Tutone, M. & Lauria, A. (2009) A QSAR study investigating
the potential anti-HIV-1 effect of some Acyclovir and Ganciclovir analogs.
ARKIVOC. (viii): 85-94.
4. Gálvez, J.; García-Doménech, R.; de Julián-Ortiz, J. V. & Soler, R. (1995)
Topological Approach to Drug Design. Journal of Chemical Information and
Computer Sciences. 35(5): 272-284.
5. Gozalbes, R.; Brun-Pascuad, M.; García-Doménech, R.; Gálvez, J.; Girard, P.
M.; Ddoucet, J. P. & Derouin, F. (2000) Anti-Toxoplasma activities of 24 ui-
nolones and Fluoroquinolones in vitro: Prediction of activity by molecular
topology and virtual computational techniques. Antimicrobial Agents and Che-
motherapy. 44(10): 2771-2776.
6. Julián-Ortiz, J. V.; Gálvez, J.; Muñoz-Collado, C.; García-Doménech, R. &
Gimeno-Cardona, C. (1999) Virtual combinatorial syntheses and computatio-
nal screening of new potential anti-herpes compounds. Journal of Medicinal
Chemistry. 42(17): 3308-3314.
7. Duart, M. J.; Antón-Fos, G. M.; Alemán, P. A.; Gay-Roig, J. B.; González-
Rosende, M. E.; Gálvez, J. & García-Doménech, R. (2005) New potential
antihistaminic compounds. Virtual combinatorial chemistry, computational
screening, real synthesis, and pharmacological evaluation. Journal of Medici-
nal Chemistry. 48(4): 1260-1264.
8. García-Doménech, R.; Gálvez, J.; Julián-Ortiz, J. V. & Pogliani, L. (2008) Some
new trends in chemical graph theory. Chemical Reviews. 108(3): 1127-1169.
9. Mahmoudi, N.; García-Doménech, R.; Gálvez, J.; Farhati, M.; Franetich, J.-F.;
Sauerwein, R.; Hannoun, L.; Derouin, F.; Danis, M. & Mazier, D. (2008) New
active drugs against liver stages of Plasmodium predicted by molecular topo-
logy. Antimicrobial Agents and Chemotherapy. 52(4): 1215-1220.
10. García-Doménech, R.; Domingo-Puig, C. & Esteve-Martínez, M. A. (2008)
Aplicación de la topología molecular en la búsqueda de nuevos agentes activos
frente a Leishmania. Anales de la Real Academia de Farmacia. 74(3): 345-367.
11. Kier, L. B.; Murray, W. J.; Randic, M. & Hall, L. H. (1975) Molecular connec-
tivity V: connectivity series concept applied to density. Journal of Pharmaceu-
tical Sciences. 65(8): 1226-1230.
12. Kier, L. B. & Hall, L. H. (1982) General definition of valence delta-values for
molecular connectivity. Journal of Pharmaceutical Sciences. 72(10): 1170-1173.
13. Gálvez, J.; García-Doménech, R.; Salabert, M. T. & Soler, R. (1994) New
Topological Descriptors. Journal of Chemical Information and Computer Scien-
ces. 34(3): 520-525.

56